Optimizing antibiotic therapy of group IV community-acquired pneumonia patients.

Combination antibiotic therapy for community-acquired pneumonia

Community-acquired pneumonia (CAP) is a common and potentially serious illness that is associated with morbidity and mortality. Although medical care has improved during the past decades, it is still potentially lethal. Streptococcus pneumoniae is the most frequent microorganism isolated. Treatment includes mandatory antibiotic therapy and organ support as needed. There are several antibiotic t...

Antibiotic timing in community-acquired pneumonia patients.

Empiric antibiotic therapy in children with community-acquired pneumonia.

OBJECTIVE To assess the possible change of clinical response to empiric antibiotic therapy among children survivors hospitalized with community-acquired pneumonia at a teaching hospital during 1991-2001. METHODS This was a retrospective observational study. The medical records of children (aged 29 days to 12 years) with diagnosis of presumed bacterial pneumonia at hospital discharge were revi...

Antibiotic administration in community-acquired pneumonia.

2004;126;320-321 Chest Bartlett Peter M. Houck, Dale W. Bratzler, Wato Nsa, Allen Ma and John G. Community-Acquired Pneumonia Antibiotic Administration in http://chestjournal.org and services can be found online on the World Wide Web at: The online version of this article, along with updated information ). ISSN: 0012-3692. http://www.chestjournal.org/misc/reprints.shtml ( of the copyright holde...

Antibiotic Administration in Community-Acquired Pneumonia

bronchial hyperresponsiveness using methacholine and adenosine monophosphate: relationship to asthma severity and (2)-receptor genotype. Am J Respir Crit Care Med 2000; 162:1318–1322 8 Koskela HO, Hyvärinen L, Brannan JD, et al. Responsiveness to three bronchial provocation tests in patients with asthma. Chest 2003; 124:2171–2177 9 Hunter CJ, Brightling CE, Woltmann G, et al. A comparison of th...